These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12655470)
21. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650 [TBL] [Abstract][Full Text] [Related]
22. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003. Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461 [TBL] [Abstract][Full Text] [Related]
23. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis. Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS; AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811 [TBL] [Abstract][Full Text] [Related]
24. Gender-specific considerations in the antiretroviral management of HIV-infected women. Clark RA; Squires KE Expert Rev Anti Infect Ther; 2005 Apr; 3(2):213-27. PubMed ID: 15918779 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with vertical HIV transmission during two different time periods: the impact of zidovudine use on clinical practice at a Brazilian reference centre. Mussi-Pinhata MM; Kato CM; Duarte G; Paschoini MC; Bettiol H; Quintana SM Int J STD AIDS; 2003 Dec; 14(12):818-25. PubMed ID: 14678590 [TBL] [Abstract][Full Text] [Related]
26. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission. Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984 [TBL] [Abstract][Full Text] [Related]
28. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK; Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808 [TBL] [Abstract][Full Text] [Related]
29. [Antiretroviral therapy in HIV/AIDS seropositive pregnant women in Cuba]. González Núñez I; Díaz Jidy M; Pérez Avila J; Mengana Gutiérrez HL Rev Cubana Med Trop; 2004; 56(1):70-2. PubMed ID: 15849913 [TBL] [Abstract][Full Text] [Related]
30. [HIV and pregnancy]. Petry KU MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880 [TBL] [Abstract][Full Text] [Related]
31. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004. Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG; Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299 [TBL] [Abstract][Full Text] [Related]
32. Perinatally acquired HIV-1 infection: prevention and evaluation of HIV-exposed infants. Shetty AK Semin Pediatr Infect Dis; 2005 Oct; 16(4):282-95. PubMed ID: 16210108 [TBL] [Abstract][Full Text] [Related]
33. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects]. Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999 [TBL] [Abstract][Full Text] [Related]
34. Recommendations for the use of antiretroviral drugs in pregnant women infected with HIV. Rose V Am Fam Physician; 1998 Jul; 58(1):261-3. PubMed ID: 9672440 [No Abstract] [Full Text] [Related]
35. Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients. Viganò A; Cerini C; Pattarino G; Fasan S; Zuccotti GV Expert Opin Drug Saf; 2010 May; 9(3):431-45. PubMed ID: 20078250 [TBL] [Abstract][Full Text] [Related]
36. Use of enhanced perinatal human immunodeficiency virus surveillance methods to assess antiretroviral use and perinatal human immunodeficiency virus transmission in the United States, 1999-2001. Harris NS; Fowler MG; Sansom SL; Ruffo N; Lampe MA Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S33-41. PubMed ID: 17825649 [TBL] [Abstract][Full Text] [Related]
37. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States. American Academy of Pediatrics Committee on Pediatric AIDS Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995 [TBL] [Abstract][Full Text] [Related]
38. Plasma lopinavir trough levels in a group of pregnant women on lopinavir, ritonavir, zidovudine, and lamivudine. Manavi K; McDonald A; Al-Sharqui A AIDS; 2007 Mar; 21(5):643-5. PubMed ID: 17314527 [TBL] [Abstract][Full Text] [Related]
39. Zidovudine administration during pregnancy and mitochondrial disease in the offspring. Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167 [TBL] [Abstract][Full Text] [Related]
40. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants. Prasitwattanaseree S; Lallemant M; Costagliola D; Jourdain G; Mary JY Antivir Ther; 2004 Apr; 9(2):179-85. PubMed ID: 15134179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]